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A paper in this issue by Ogawa et al. (2013) shows that HSV-2-infected keratinocytes in human skin explants
release a protein that enhancesHIV-1 infection of Langerhans cells in vitro. Thismay explain the in vivo obser-
vation that HSV-2 infection facilitates HIV-1 acquisition.Most of our experimental knowledge
regarding molecular and cellular mecha-
nisms of HIV-1 infection comes from labo-
ratory experiments in which cultures of
isolated cells are infected with HIV-1
isolates and the infections are monitored.
Of course, the cultures should be sterile,
as we do not report on cell cultures that
are contaminated by other microbes.
Real life, however, is different. Far from
being sterile, our bodies are populated by
different microbes, including viruses. In
HIV-infected individuals, some of these
resident viruses reactivate, and others
invade, soon after HIV-1. These viruses
are involved in a sort of a microbial
‘‘war and peace’’ (Lisco et al., 2009), a
complex network of interactions (Virgin
et al., 2009) in which some viruses facili-
tate or suppress each other’s infections.
Also, viruses exploit the host’s defensive
responses for their benefit.
Deciphering the mechanisms of these
virus-virus interactions would not only be
an important step in understanding viral
pathogenesis, but may also lead to new
therapeutic strategies (e.g., by pitting
one virus against another [Bhattarai and
Stapleton, 2012]).
Work published in this issue of Cell
Host & Microbe by Ogawa et al. (2013)
constitutes a significant step in under-
standing the interactions between two
important human viral pathogens, herpes
simplex virus-2 (HSV-2) and HIV-1.
HSV-2 is a common HIV copathogen,
which is involved with HIV in a vicious
cycle of each virus facilitating the other’s
transmission and infection. In particular,
genital herpes, caused by HSV-2, signifi-
cantly increases the chances of acquiring
HIV-1 (Corey et al., 2004). Initially it was
thought that merely the presence of
genital ulcers in HSV-2-infected individ-
uals provided HIV-1 a direct access toits target cells, which are otherwise pro-
tected by the epithelia, and fully explains
HSV-2’s association with enhanced HIV
transmission. Further studies, however,
have revealed that the mechanisms of
HSV-2/HIV-1 interaction aremore compli-
cated (Van de Perre et al., 2008). Indeed,
even without visible ulcers, HSV-2-acti-
vated CD4+ T cells persist at the mucosa,
thus providing additional targets for HIV
(Zhu et al., 2009). Moreover, HSV-2 in-
creases the HIV-1 load in already-infected
individuals, probably because of herpes-
virus-mediated immunoactivation, which
facilitates HIV-1 replication. The exis-
tence of complex HSV-2/HIV-1 interac-
tions was also evidenced during clinical
trials in which specific antiherpesvirus
therapy decreased the HIV-1 load in coin-
fected individuals (Van de Perre et al.,
2008; Vanpouille et al., 2009). It is impor-
tant to understand the involvement of
HSV-2 in the enhancement of HIV-1 trans-
mission and replication.
Ogawa et al. (2013) addressed the role
of HSV-2 infection in HIV-1 transmission
mediated by Langerhans cells (LCs),
a subset of dendritic cells (DCs). DCs in
general and LCs in particular are abun-
dant at many sites of HIV entry, particu-
larly in the foreskin and vagina. One of
the most important natural functions of
DCs is to take up an antigen and carry it
to the local lymph nodes to present to
lymphocytes, thus triggering an immune
response. HIV-1 may exploit this defense
mechanism for its own benefit using DCs
as a vehicle to reach lymphoid tissue,
rich in CD4 T lymphocytes that readily
replicate the virus and disseminate it
through the body.
Whether the DCs themselves become
productively infected by HIV-1 is a matter
of controversy, in part because of the
lack of a precise definition of DCs. In spiteCell Host & Microbeof the common morphological feature,
namely long outgrowths (dendrites), DCs
arehighlyheterogeneousand includecells
of various functions and even distinct
lineages. To add to the semantic com-
plexity, in vitro we distinguish ‘‘mature’’
and ‘‘immature’’ DCs, which interact with
HIV-1 differently (Wu and KewalRamani,
2006). The use of different experimental
models further adds to the controversies
regarding DC infection by HIV.
Historically, LCs are the first DCs to
have been discovered, and they are
named for their discoverer, a great
German microscopist who, in the course
of his short life, made important contribu-
tions to histology. Although LCs are well-
defined, the controversy about their
productive HIV-1 infection remains. While
Ogawa et al. found epidermal LCs to be
productively infected in vitro, others (Ball-
weber et al., 2011) studying mucosal LCs,
also in vitro, could not find signs of
productive HIV-1 infection.
The experiments of Ogawa et al. were
performed with explants of human blister
roofs (developed by vacuum suction).
Upon HIV-1 infection, LCs in this system
can capture and produce virus, migrate
out of the explants, and transmit infection
to T cells.
In this experimental setting, Ogawa
et al. investigated the effect of HSV-2 on
HIV-1 infection. Despite their system
being simpler than in vivo conditions,
HSV-2 performed similarly to what has
been observed in infected individuals: it
upregulated HIV-1 production and trans-
mission. Specifically, LCs in skin explants
produced more HIV-1 and, upon contact
with cultured T cells, efficiently trans-
mitted infection. Since HSV-2 can infect
LCs, one might suppose that HSV-2/
HIV-1-coinfected cells were the main
source of this increased production.13, January 16, 2013 ª2013 Elsevier Inc. 1
Figure 1. Ex Vivo Experiments and Their In Vivo
Extrapolations
Upon exposure of skin explants to HSV-2 (green hexagons and
green arrows), the infected keratinocytes (green cells) release
(blue arrow) antimicrobial peptides. Among these is LL-37
(blue dots), which augments HIV-1 (brown) infection of resident
Langerhans cells (LCs). In vitro, LCs that have been exposed to
HSV-2 transmit HIV-1 to T lymphocytesmore efficiently thando
LCs from explants not exposed to HSV-2. If a similar phenom-
enonoccurs in vivo (gray colors), i.e., if genital herpes augments
the efficiency with which LCs disseminate HIV-1 to local lymph
nodes, this augmentation may explain the increased rate of
HIV-1 transmission to HSV-2-infected individuals.
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tion was too small to account for
this increase; therefore, the mecha-
nism of this phenomenon had to
involve intercellular interactions. In-
vestigating this, the authors found
that conditioned medium from
HSV-2-infected explants upregu-
lates HIV-1 infection of LCs. Thus,
HIV-1 upregulation is mediated by
a soluble factor produced by HSV-
2-infected cells in the skin explants.
The authors took advantage of the
fact that many soluble factors pro-
duced by skin cells—in particular
by keratinocytes, the next-door
neighbors of LCs and main targets
for HSV-2 infection—have already
been identified. These identified
soluble factors include various anti-
microbial peptides (AMPs), one of
the first lines of innate immune
defense against microbes.
Ogawaet al. found that LL-37, one
of the AMPs produced by keratino-
cytes in response to HSV-2 infec-
tion, stronglyenhancedHIV infection
of LCs (Figure 1), again demon-
strating the vicious ability of HIV-1
to convert the defense of our body
into a stimulus for its own replication.
Using several strategies, the authors
convincingly show that LL-37, rather
than other known AMPs, plays a
critical role in making LCs particu-
larly susceptible to HIV-1 infection.
This LL-37-driven enhancement
was associated with upregulated
expression of the HIV-1 receptors
CD4 and CCR5 on the surface
of LCs, suggesting a mechanism
for the observed effect. Further, LL-
37 enhanced HIV-1 susceptibility
specifically of LCs, but the same
antimicrobial peptide inhibits HIV-1
infection of myeloid DCs (Ogawa
et al., 2013), adding yet another
piece of evidence for the important
role of LCs in HIV-1 transmission.
In summary, this work provides
a new insight into the mechanism
of interviral interactions within host
tissue, an elegant tango that actually
involves more than two participants,
namely three cell types (keratino-
cytes, LCs, and T lymphocytes)
and two viruses (HSV-2 and HIV-1).
It is difficult to imagine that such
a mechanism could be deciphered2 Cell Host & Microbe 13, January 16, 2013 ª2013 Elsevier Inc.in experiments using only cell lines
or single-cell primary cultures. Com-
plex systems, which adequately
reflect the complexity of the in vivo
situation, such as the explants
used in this study by Ogawa et al.
are required to decipher the com-
plex polymicrobial interactions as
they occur within multicellular hosts
in nature. Of course, compared to
a complex in vivo setting, even the
explants are a highly simplified
system, and such findings should
be extrapolated to the in vivo situa-
tion (Figure 1) with great caution,
starting with the role of DCs in
HIV-1 transmission in vivo.
HSV-2 infection likely triggers the
release of many AMPs in vivo, and
most of them, unlike LL-37, probably
do not betray their function in the
defense of our body. Moreover,
even in vitro, LL-37 itself works
against HIV-1 in other contexts by
suppressing infection of T cells. So
it is difficult to predict whether
a combination of AMPs including
LL-37will enhanceorsuppress infec-
tion in vivo, and even if it enhances at
the LC level, this may be compen-
sated for by AMP action at other
levels, e.g., by suppressing T cell
infection in the local lymph node.
On the other hand, LL-37 may not
be the only bad apple in the barrel
of the defense molecules. As with
LL-37, HIV may exploit other AMPs
at particular stages of transmission,
easing virus penetration through the
multiple gatekeepers that evolution
has put in the way of HIV-1 dissemi-
nation through our bodies.
Although all of these questions
should ultimately be answered in
a clinical setting, it is basic science
that should guide us through the
jungles of in vivo mechanisms. This
work by Ogawa et al. is an excellent
example of such basic science
research, which has revealed new
aspects of the complex, clinically
relevant interactions of HIV-1 with
its copathogen, HSV-2.REFERENCES
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Staphylococcus aureus epidemic strain USA300 is a highly successful pathogen. However, the underlying
basis of this success is not clear. Now, Thurlow and colleagues (2013) provide evidence linking the bacterial
arginine catabolic mobile element (ACME) to the dominance of USA300 as a pathogen of the skin.Human skin provides a physical barrier
and first line of immunological defense
against noxious stimuli and harmful insult.
External layers of the skin are particularly
inhospitable to pathogenic microbes.
The lowmoisture content, marked acidity,
and abundance of resident microbes on
the outer layers of the skin, the epidermis,
provide a physical barrier that can keep
the most successful pathogens at bay
(Miller and Cho, 2011). If an organism
breaches these physical barriers, the
skin has the capacity to recognize
molecular determinants of pathogenic
microbes to facilitate host cell signaling
and immune cell chemotaxis, thereby
bolstering the immune response and
providing an additional level of defense
(Miller and Cho, 2011).
Staphylococcus aureus is a bacterium
that is capable of rapid adaptation to
host insult in order to promote survival in
disparate conditions. The organism is
notorious for its ability to cause skin and
soft tissue infections. Through gene
acquisition and alterations in regulatory
networks, S. aureus is able to counter
the physical and immunological barriers
of the skin. Some of its defense tactics
include the production of specialized
binding proteins, immune evasion mole-cules, and immune cell targeting toxins
(Foster, 2005). As a result, S. aureus
has become one of the leading causa-
tive agents of skin and soft tissue infec-
tions. Its environmental adaptability
coupled with an increase in antibiotic
resistance among infectious isolates
make S. aureus a major public health
concern.
S. aureus strains exhibit periodic shifts
in the clonal lineage responsible for wide-
spread disease (Li et al., 2009). In the
USA, the current epidemic strain of meth-
icillin-resistant S. aureus, MRSA, is the
sequence type 8 strain, USA300. Consid-
erable attention has been given to the
analysis of USA300 virulence and the
factors responsible for its rise to domi-
nance in both community and clinical
settings (Li et al., 2009; Montgomery
et al., 2008). Indeed, well-known virulence
factors such as alpha hemolysin, phenol
soluble modulins (PSMs), and the Pan-
ton-Valentine leukocidin are produced at
higher levels in these strains (Li et al.,
2009). Additionally, USA300 isolates
have higher activities of gene regulatory
systems including the accessory gene
regulatory system Agr (Li et al., 2009).
While increased Agr activity and en-
hanced production of toxins are likely tocontribute to the overall pathogenic
potential of USA300, they do not fully
explain its propensity to cause skin and
soft tissue infection.
An additional genetic locus harbored by
USA300 strains is the arginine catabolic
mobile element (ACME). ACME is a 33-
gene locus that contains genes important
for arginine catabolism (Arc), an oligo-
peptide permease system (opp3), and
a polyamine N-acetyl transferase (speG).
In USA300, ACME is genetically linked
to the staphylococcal chromosomal
cassette mec (SCCmec) type IVa (Diep
et al., 2008). SCCmec confers b-lactam
resistance to S. aureus. The genetic
linkage between SCCmec and ACME
was observed by Diep et al. and is
believed to be present in nearly all
USA300 isolates (Diep et al., 2008). It
was postulated that the presence of
ACME, which confers a modest fitness
advantage to USA300, coupled with the
antibiotic resistance associated with
SCCmec typeIVa could provide a suitable
explanation for the increased dominance
of USA300. However, additional studies
have demonstrated that the increased
fitness of ACME-containing USA300
strains may not necessarily lead to an
increase in virulence (Montgomery et al.,13, January 16, 2013 ª2013 Elsevier Inc. 3
